Patents by Inventor William Rosenberg

William Rosenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120231010
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The compounds include the salts, hydrates and isomers thereof. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: May 17, 2012
    Publication date: September 13, 2012
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Patent number: 8198292
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The compounds include the salts, hydrates and isomers thereof. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: June 12, 2012
    Assignee: Osteogenex, Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Patent number: 8188065
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Grant
    Filed: October 1, 2009
    Date of Patent: May 29, 2012
    Assignee: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20120066745
    Abstract: Devices and methods are disclosed which relate to managing multiple public user identifiers (PUIDs) in a database by setting customizable access rules and requiring authorization from applications for access. These PUIDs can be virtually any electronic identifier such as a telephone number, email address, FACEBOOK name, etc. The PUID database is on the memory of a mobile communication device. Applications on the mobile communication device or on the network request access to the PUID database. Access logic on the mobile communication device checks another database of PUID Access Policies and Preferences (PAPP) for authorization. The PAPP database may allow the application immediate access, deny access, or query the user for allowance. The PUID database and PAPP database are on a server on a network.
    Type: Application
    Filed: September 11, 2010
    Publication date: March 15, 2012
    Applicant: AT&T INTELLECTUAL PROPERTY I, L.P.
    Inventors: Mark Steven Wuthnow, Richard R. Erickson, William Rosenberg
  • Publication number: 20120054287
    Abstract: A method and system for converting data message formats in a message server is provided. The message server receives a first data message including origin format information from a first user. The message server then sends the first data message including origin format information to a second user. The message server receives a second data message from a second user, the second data message including the origin format. The second data message is converted to the origin format if the first user is unable to receive the second data message. The message server then sends the converted second data message to the first user.
    Type: Application
    Filed: September 1, 2010
    Publication date: March 1, 2012
    Applicant: AT&T MOBILITY II, LLC
    Inventors: Matthew Stafford, Vinod Pandey, William Rosenberg, Jerry Shih
  • Patent number: 8080575
    Abstract: The present invention provides compounds, compositions and methods for promoting bone growth. Compounds useful in the methods of the present invention include compounds of Formula I, wherein each R1 and R2 is H, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkoxy, —OR4, —NR4R5, —SR4, —C(O)R4, —C(O)OR4, —C(O)NR4R5, —N(R4)C(O)R5, —N(R4)C(O)OR5, —N(R4)C(O)NR4R5, —OP(O)(OR4)2, —S(O)2OR4, —S(O)2NR4R5, —CN, cycloalkyl, heterocycloalkyl, aryl or heteroaryl. Each R4 and R5 is H or C1-6 alkyl. X is O, S or NR4. Y is an aryl ring system having 6-10 ring members or a heteroaryl ring system having 5-10 ring members where 1-3 ring members are each N, O or S. Subscript n is 1 or 2. The compounds also include salts, hydrates and isomers of the compounds of the present invention.
    Type: Grant
    Filed: May 26, 2009
    Date of Patent: December 20, 2011
    Assignee: Osteogenex Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20110176491
    Abstract: A method includes receiving a registration request including a first dictionary definition. The registration request is associated with user equipment. The method includes transmitting to the user equipment a response including a second dictionary definition. The method includes transmitting subsequent messages to the user equipment if the first and second dictionary definitions agree, the subsequent messages being compressed using the first static dictionary.
    Type: Application
    Filed: April 4, 2011
    Publication date: July 21, 2011
    Inventors: Matthew Stafford, Kennie Y. Kwong, Mark S. Wuthnow, William Rosenberg
  • Publication number: 20110136519
    Abstract: Systems, methods, and apparatus that facilitate effective routing of short message service (SMS) and multimedia messaging service (MMS) messages via short codes are presented herein. A group message component can be configured to receive a message transmitted via a wireless communications device, and determine whether the message comprises at least two addressees. A short code component can be configured to identify whether the at least two addressees are associated with at least one short code, and recognize whether the message comprises only text. A routing component can be configured to convert the message to an SMS message when the message comprises the at least two addressees, the at least two addressees are associated with the at least one short code, and the message comprises only text. Further, the routing component can be configured to route the SMS message to the at least one short code.
    Type: Application
    Filed: December 8, 2009
    Publication date: June 9, 2011
    Applicant: AT&T MOBILITY II LLC
    Inventors: Matthew Bailey, Chris Bryant, William Rosenberg
  • Publication number: 20110136492
    Abstract: System(s) and method(s) are provided for intelligent routing of communication(s) to international number(s) in a messaging service. To route a communication that includes an international number, format of the communication is established. A text-only communication is delivered through a messaging service transport protocol (MSTP) suitable for text. A media-based communication intended for a plurality of recipients, e.g., a group message, is ungrouped, the international number is identified, and a new message is generated for a group of recipients that excludes a recipient associated with the international number. The new message is delivered through a MSTP suitable for media, whereas an exception handling procedure is conducted for the international number. In addition, to route the communication that includes an international number, network interoperability of predetermined MSTP can be assessed. The communication is delivered through the predetermined MSTP if it is interoperable.
    Type: Application
    Filed: December 9, 2009
    Publication date: June 9, 2011
    Applicant: AT&T MOBILITY II LLC
    Inventors: Matthew James Bailey, Christopher Bryant, William Rosenberg
  • Publication number: 20100249171
    Abstract: The present invention provides a method of reducing body weight in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I: In Formula I, R1 is H, C1-6 alkyl, or C1-6 alkyl-aryl. Each of R2 and R4 of Formula I are independently H, halogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkoxy, —OR2a, —SR2a, —C(O)R2a, —C(O)OR2a, —C(O)NR2aR2b, —NR2aR2b, C1-6 alkyl-NR2aR2b, —N(R2a)C(O)R2b, —N(R2a)C(O)OR2b, —N(R2a)C(O)NR2aR2b, —OP(O)(OR2a)2, —S(O)2OR2a, —S(O)2NR2aR2b, —CN, —NO2, cycloalkyl, heterocycloalkyl, aryl or heteroaryl. Each of R2a and R2b of Formula I are independently H, C1-6 alkyl, C1-10 heteroalkyl or C1-6 alkyl-aryl. R3 of Formula I is absent, C1-6 alkyl or N-oxide. The compounds include the salts, hydrates and isomers thereof. The present invention also provides methods for the treatment of obesity and disorders related to obesity and higher than recommended percentage body fat, such as type II diabetes.
    Type: Application
    Filed: March 15, 2010
    Publication date: September 30, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Patent number: 7796592
    Abstract: Methods and apparatus including a virtual machine and a compression network platform are provided especially for improving the application of compression algorithms and unique identifiers for bytecode and bytecode packages including associated static dictionaries utilized to advantage in wireless networks. In particular, a given virtual machine need only identify to a receiving virtual machine the unique package identifier for one or more of an algorithm, a static dictionary or a hash for decompressing a received data signal. The receiving virtual machine may advertise what it has locally available to it so that no uploading is necessary. The actuation of bytecode by identifier may be requested at a given destination within the parameters set by RFC 3320.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: September 14, 2010
    Assignee: AT&T Mobility II LLC
    Inventors: Matthew Stafford, Kennie Y. Kwong, Mark S. Wuthnow, William Rosenberg
  • Publication number: 20100173931
    Abstract: The present invention provides a method of reducing body weight in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of obesity and disorders related to obesity and higher than recommended percentage body fat, such as type II diabetes.
    Type: Application
    Filed: January 5, 2010
    Publication date: July 8, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100143441
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: November 12, 2009
    Publication date: June 10, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100092559
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: October 1, 2009
    Publication date: April 15, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100074939
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: September 18, 2009
    Publication date: March 25, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100055183
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: August 25, 2009
    Publication date: March 4, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100047314
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: August 20, 2009
    Publication date: February 25, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg
  • Patent number: 7668661
    Abstract: The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.
    Type: Grant
    Filed: June 15, 2004
    Date of Patent: February 23, 2010
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Michael Volker, Michael Becka, Werner Kroll, Andreas Knorr, Sylvia Unger, Mathias Gehrmann, Guido Hennig, Elmar-Reinhold Burchardt, Michael J. Arthur, Alastair D. Burt, Massimo Pinzani, Detlef Schuppan, Robert P. Thiel, Christoph Petry, William Rosenberg
  • Publication number: 20100040628
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: August 11, 2009
    Publication date: February 18, 2010
    Applicant: OsteoGeneX, Inc
    Inventors: Debra Ellies, William Rosenberg
  • Publication number: 20100021524
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Application
    Filed: July 20, 2009
    Publication date: January 28, 2010
    Applicant: OsteoGeneX Inc.
    Inventors: Debra Ellies, William Rosenberg